Probiotic pouch projects: strain identity and viable count through shelf life

A probiotic pouch project needs to answer whether the organisms remain identifiable and viable in the finished formulation throughout its stated life. Adding a probiotic powder to a familiar pouch base does not establish that the organisms survive mixing, storage or the intended use.

Identify the strain, not only the species

Record the genus, species and strain designation, together with the supplier’s preparation and its carrier. NIH’s probiotic fact sheet explains why strain identification and the relevance of evidence matter: results cannot be assumed to apply across different probiotic organisms. [1]

Clarify whether the concept uses live organisms, an inactivated preparation or another microbial-derived ingredient. Those are different specifications and should not share an unexamined label claim. The method used to verify identity should be appropriate to the actual supplied material.

Define the viable-count statement

Keep raw-material potency, initial finished-product count and the promised end-of-shelf-life count separate. State the unit, test method, sampling plan and storage conditions. A high count on an ingredient certificate does not establish the count in each pouch after manufacturing or after months in a can.

Work with the laboratory on recovery from the complete matrix. Flavors, sweeteners, preservatives, carrier materials and extraction conditions can affect the suitability of the method. A generic microbial plate count may not answer the strain-specific question the product is intended to make.

Evaluate the formulation environment

Review temperature exposure, moisture, water activity, oxygen and ingredient compatibility for the selected preparation. Water activity and moisture content describe different aspects of a formulation; neither should be inferred from how a pouch feels. [2] A development plan should measure the relevant conditions and relate them to the organism and package.

Test the final pouch in the intended can or individual pack. Include opening conditions if repeated access is part of the intended use. A sealed laboratory vial can provide useful early information but does not reproduce the commercial package.

Review the evidence and category

A probiotic is not automatically suitable for every consumer or every route. NIH identifies safety considerations and the need to match the organism and evidence to the intended purpose. [1] Obtain a qualified review of the proposed product, especially where the intended exposure differs from the studies cited.

• Verified strain identity and full preparation composition.
• Viable-count method suitable for the finished pouch.
• Count specification at release and through the claimed shelf life.
• Compatibility, process exposure and final-package stability.
• Evidence and classification for the precise proposed claim.

Questions buyers ask

Is the ingredient’s CFU value the finished-pouch CFU value?

No. The material must be incorporated, recovered and tested in the finished matrix. Manufacturing and storage losses also need to be understood.

Can a postbiotic be labeled as a live probiotic?

The terminology should match the ingredient’s identity and the applicable rules. An inactivated preparation does not become a live-organism product because the species name is familiar.

Can a large initial overage replace a stability study?

No. The proposed end-of-life statement needs evidence in the final formulation and package. A large starting count cannot explain an unknown loss rate.

Explore the product specifications

• Functional pouch projects
• Quality documentation

Sources & further reading

1. NIH ODS: Probiotics, Health Professional Fact Sheet
2. FDA: Water Activity (aw) in Foods

Sources checked November 7, 2026. External research and guidance are context; they are not test results or authorizations for a Sunova finished product.